Skip to main contentAI and Advanced
/
AMANTA · BSEMarket ticker unavailable · configure an authorised index feed
AM
BSE · Equity shares · Biotechnology & Drugs3.30 · 2.00%
Amanta Healthcare AMANTA
NSE:INR 167.93
BSE:INR 168.45
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceStale · last-known data
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for AMANTA
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 165.15
Day rangeINR 165 — INR 168
52-week rangeINR 93.1 — INR 192
Volume26,413
Market cap654.08
P/E38.78
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)287.68
Net Income (INR Cr)14.88
P/E Ratio38.78
Book Value56.54
EPS4.87
Price/BV2.98Computed
Research path: Interpret Amanta Healthcare's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
AMANTAAmanta Healthcare1d · INR · BSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 557.98 | 381.76 | 352.12 |
| Long Term Debt | 161.97 | 132.36 | 149.03 |
| Common Stock Total | 38.83 | 28.83 | 26.83 |
| Other Current Assets Total | 19.34 | 4.5 | 3.03 |
| Total Assets | 557.98 | 381.76 | 352.12 |
| Current Portof LT Debt/Capital Leases | 74.48 | 22.7 | 51.31 |
| Cash | 81.01 | 0.22 | 1.54 |
| Total Equity | 220.21 | 96.39 | 66.29 |
| Long Term Investments | 15.58 | 8.64 | 4.75 |
| Retained Earnings(Accumulated Deficit) | 181.38 | 28.58 | 18.48 |
| Total Common Shares Outstanding | 3.88 | 3.88 | 3.88 |
| Tangible Book Valueper Share Common Eq | 56.54 | 24.59 | 17.07 |
| Total Liabilities | 337.77 | 285.37 | 285.83 |
| Total Debt | 244.44 | 203.94 | 211.09 |
| Short Term Investments | 11.93 | 3.27 | 2.56 |
| Cashand Short Term Investments | 92.94 | 3.49 | 4.1 |
| Total Receivables Net | 43.53 | 50.54 | 48.35 |
| Deferred Income Tax | 26.75 | 30.19 | 29.71 |
| Accounts Receivable-Trade Net | 43.02 | 50.08 | 48.17 |
| Property/Plant/Equipment Total-Net | 288.01 | 222.77 | 228.13 |
| Total Current Liabilities | 141.06 | 115.08 | 101.66 |
| Total Inventory | 82.71 | 72.98 | 59.45 |
| Accounts Payable | 35.89 | 30.5 | 24.8 |
| Other Currentliabilities Total | 30.69 | 8.85 | 20.22 |
| Total Long Term Debt | 169.97 | 140.1 | 154.46 |
| Intangibles Net | 0.69 | 0.92 | 0.02 |
| Other Long Term Assets Total | 14.84 | 11.31 | 1.21 |
| Note Receivable-Long Term | 0.33 | 0.21 | 0.12 |
| Total Current Assets | 238.53 | 137.92 | 117.89 |
| Capital Lease Obligations | 8 | 7.74 | 5.43 |
| Accumulated Depreciation Total | Not available | -65.38 | -49.65 |
| Accrued Expenses | Not available | 11.89 | Not available |
| Prepaid Expenses | Not available | 6.41 | 2.95 |
| Additional Paid-In Capital | Not available | 38.98 | 20.98 |
| Property/Plant/Equipment Total-Gross | Not available | 281.6 | 277.78 |
| Notes Payable/Short Term Debt | Not available | 41.14 | 5.32 |
Fundamentals
Valuation and ratios
Valuation
Price to Sale Ratio2.27
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk45.04
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | INR 1,934.7 | 4.64 L | 38.87 | — |
| Divi's Laboratories | INR 7,367.5 | 1.96 L | 74.03 | — |
| Torrent Pharmaceuticals | INR 4,967.35 | 1.68 L | 76.43 | — |
| Cipla | INR 1,406 | 1.14 L | 28.01 | — |
| Zydus Lifesciences | INR 1,116 | 1.11 L | 21.29 | — |
Shareholding
Ownership
- Promoter
- 63.80%
- FII
- 0.43%
- MF
- 5.33%
- Other
- 30.44%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Enterprise value to EBITDA forward of Amanta Healthcare Limited – BSE:AMANTA - TradingViewMarket news · 14 Jul 2026, 6:43 pm
Enterprise value to EBITDA forward of Amanta Healthcare Limited – BSE:AMANTA TradingView
Price to book forward of Amanta Healthcare Limited – BSE:AMANTA - TradingViewMarket news · 14 Jul 2026, 6:42 am
Price to book forward of Amanta Healthcare Limited – BSE:AMANTA TradingView
Amanta Healthcare - Unique Picks: 7 stocks held by a single MF scheme in June; rally up to 120% in 3 months - The Economic TimesMarket news · 11 Jul 2026, 12:13 pm
Amanta Healthcare - Unique Picks: 7 stocks held by a single MF scheme in June; rally up to 120% in 3 months The Economic Times
Broad-Based Technical Strength Lifts Amanta Healthcare Ltd to 52-Week High of Rs 192 - MarketsMojoMarket news · 9 Jul 2026, 10:00 am
Broad-Based Technical Strength Lifts Amanta Healthcare Ltd to 52-Week High of Rs 192 MarketsMojo
Amanta Healthcare Ltd Valuation Shifts Amid Strong Market Performance - MarketsMojoMarket news · 9 Jul 2026, 9:49 am
Amanta Healthcare Ltd Valuation Shifts Amid Strong Market Performance MarketsMojo
Amanta Healthcare Downgraded to Sell Amid Mixed Technicals and Valuation Concerns - MarketsMojoMarket news · 9 Jul 2026, 8:51 am
Amanta Healthcare Downgraded to Sell Amid Mixed Technicals and Valuation Concerns MarketsMojo
Corporate actions
Events
- board MeetingsAudited Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for Amanta Healthcare
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Amanta Healthcare Ltd is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and marketing a diverse range of sterile liquid products-parenteral products, being packed in plastic containers with Aseptic Blow-Fill-Seal (ABFS) and Injection Strech Blow Molding (ISBM) technology. The Company manufactures large volume parenteral (LVPs) and small volume parenteral (SVPs) in six therapeutic segments. In addition to that, it also manufactures medical devices. The Company manufactures fluid therapy- (IV Fluid), formulations, diluents, ophthalmic, respiratory care and irrigation solutions in the therapeutic segment and products like irrigation, first-aid solutions, eye lubricants in the medical device segment. It also offers a various range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume ranging from two milliliters (ml) to 1000 ml.
Company facts
- Industry
- Biotechnology & Drugs
- Sector
- Biotechnology & Drugs
- NSE Code
- AMANTA
- BSE Code
- 544502
Questions
Stock FAQ
What is the symbol and ISIN of Amanta Healthcare?
Amanta Healthcare has the symbol AMANTA and ISIN - INE084K01015.
What is the current price of Amanta Healthcare?
Amanta Healthcare is currently trading at INR 168.45.
What are the year high and year low of Amanta Healthcare?
Amanta Healthcare has a year high of INR 192.00 and a year low of INR 93.10.
What is the market capitalization of Amanta Healthcare?
Amanta Healthcare has a market capitalization of INR 654.08 crore.
What is the P/E ratio of Amanta Healthcare?
Amanta Healthcare has a P/E ratio of 38.78.
What is the dividend yield of Amanta Healthcare?
Amanta Healthcare has a dividend yield of NA.
How is the financial performance of Amanta Healthcare based on revenue, net income, and EPS?
Amanta Healthcare has revenue of INR 287.68 crore, net income of INR 14.88 crore, and EPS of NA.
What is the book value of Amanta Healthcare?
Amanta Healthcare has a book value of INR 56.54.
What is the debt-to-equity ratio of Amanta Healthcare?
Amanta Healthcare has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Amanta Healthcare?
Amanta Healthcare has a price-to-book ratio of 2.98 and a price-to-sales ratio of 2.27.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.